Mylan NV (NASDAQ:MYL)

16.11
Delayed Data
As of Jul 07
 -0.43 / -2.60%
Today’s Change
12.75
Today|||52-Week Range
23.11
-19.85%
Year-to-Date
Should You Buy These 3 Stocks Tackling Alzheimer's Disease?
Jun 29 / MotleyFool.com - Paid Partner Content
Is This Bargain Biotech Stock a Treasure or a Trap?
Jun 27 / MotleyFool.com - Paid Partner Content
Should You Sell Your Pfizer Stock Now?
Jun 27 / MotleyFool.com - Paid Partner Content
Sanofi's Cost-Cutting Could Mean Big Job Losses
Jun 25 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close16.54
Today’s open16.33
Day’s range15.95 - 16.55
Volume5,491,232
Average volume (3 months)7,531,846
Market cap$8.2B
Data as of 4:15pm ET, 07/07/2020

Growth & Valuation

Earnings growth (last year)-95.28%
Earnings growth (this year)-1.13%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+0.64%
P/E ratio134.3
Price/Sales0.90
Price/Book0.69

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-0.01-0.02%
IONSIonis Pharmaceutical...+0.62+1.01%
ACADACADIA Pharmaceutica...+3.31+6.17%
PRGOPerrigo Company PLC-0.02-0.04%
Data as of 4:00pm ET, 07/07/2020

Financials

Next reporting dateAugust 5, 2020
EPS forecast (this quarter)$0.99
Annual revenue (last year)$11.5B
Annual profit (last year)$16.8M
Net profit margin0.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
No executives to display
Corporate headquarters
Hatfield, Hertfordshire

Forecasts